Watertown Biotech Company Seeks to Create Coronavirus Treatment

The following announcement was sent out by Watertown-based Enanta Pharmaceuticals:

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that it has initiated a program to discover direct-acting antiviral drug candidates for the treatment of patients infected with the novel coronavirus COVID-19, also known as SARS-CoV-2.